Free cash flow
Revolution Medicines, Inc. Free cash flow decreased by 28.8% to -$355.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 79.9%, from -$197.70M to -$355.70M. Over 4 years (FY 2021 to FY 2025), Free cash flow shows a downward trend with a 56.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Detailed definition
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Peer comparison
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flowHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$35.39M | -$37.04M | -$40.45M | -$57.05M | -$58.24M | -$55.26M | -$64.66M | -$64.15M | -$68.24M | -$103.03M | -$122.88M | -$163.73M | -$130.57M | -$133.94M | -$139.51M | -$197.70M | -$229.21M | -$210.66M | -$276.16M | -$355.70M |
| QoQ Change | — | -4.7% | -9.2% | -41.0% | -2.1% | +5.1% | -17.0% | +0.8% | -6.4% | -51.0% | -19.3% | -33.2% | +20.3% | -2.6% | -4.2% | -41.7% | -15.9% | +8.1% | -31.1% | -28.8% |
| YoY Change | — | — | — | — | -64.6% | -49.2% | -59.9% | -12.4% | -17.2% | -86.4% | -90.0% | -155.2% | -91.3% | -30.0% | -13.5% | -20.8% | -75.5% | -57.3% | -97.9% | -79.9% |
Free cash flow at Other Companies
Frequently Asked Questions
- What is Revolution Medicines, Inc.'s free cash flow?
- Revolution Medicines, Inc. (RVMD) reported free cash flow of -$355.70M in Q1 2026.
- How has Revolution Medicines, Inc.'s free cash flow changed year-over-year?
- Revolution Medicines, Inc.'s free cash flow decreased by 79.9% year-over-year, from -$197.70M to -$355.70M.
- What is the long-term trend for Revolution Medicines, Inc.'s free cash flow?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s free cash flow has grown at a 56.1% compound annual growth rate (CAGR), from -$153.71M to -$913.73M.
- What does free cash flow mean?
- The cash remaining after a company pays for its operating expenses and capital investments.